Trial · NCT05419583
Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction
NCT05419583, Not applicable, Completed, University of Edinburgh
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction. Trials, record NCT05419583. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05419583
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction
- NCT number
- NCT05419583
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 60 participants, actual
- Lead sponsor
- University of Edinburgh
- Conditions
- Myocardial Infarction Type 2
- Interventions
Coronary computed tomography angiography, Invasive coronary angiography, Transthoracic echocardiography, Cardiac MRI scan, Antiplatelet Drug (Aspirin or Statin), Anticoagulants (Apixaban, Edoxaban, Rivaroxoban, Warfarin), Guideline directed heart failure therapy, Statins (Cardiovascular Agents)
- First posted
- 2022-06-15
- Last updated
- 2024-09-19
Source ClinicalTrials.gov
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Trial process outcomes: eligibility, approach, consent and randomisation | 90 days | The proportion of patients who are eligible, approached, consented and randomised |
| Secondary | Recruitment rate | 30 days and 90 days | Rate per month and overall |
| Secondary | Adherence to recommended investigation | 90 days | Determined as the proportion of patients who received recommended investigation |
| Secondary | Adherence to recommended treatment | 90 days | Determined as the proportion of patients who received recommended treatment |
| Secondary | Proportion of patients with changes in prescription of secondary prevention therapy | 90 days | Defined as initiation, intensification or cessation of cardiac medication including aspirin, clopidogrel, statin, bisoprolol or ACE-inhibitor and others as defined in data dictionary. |
| Secondary | Frequency of investigation and treatment | 90 days | Proportion of patients who undergo routine cardiac investigation (echocardiography, invasive coronary angiography, percutaneous coronary intervention, CT coronary angiography, cardiac MRI) in the standard care arm per month |
| Secondary | Change in classification of myocardial infarction | 90 days | Proportion of patients in whom the classification of myocardial infarction changes after study intervention |
| Secondary | Quantity of missing data | Baseline and 90 days | |
| Other | Rate of myocardial infarction | 90 days | As per the Fourth Universal Definition |
| Other | Rate of all-cause death | 90 days |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05419583
GET https://conductscience.org/api/trials/v1/NCT05419583/registered